All
Geneticist takes you inside the skin microbiome
August 17th 2020Geneticist Thomas M. Hitchcock, Ph.D., explores the relationship between skin and its microbes. Through a series of interviews with dermatology experts, he shares insight into what is the skin microbiome and why it is critical to skin health.
HIFU technology making waves with multiple treatment indications
August 12th 2020A Danish dermatology company releases their new HIFU device, TOOsonix System ONE-M, for treatment of color-independent tattoo removal, spider veins, lentigines, telangiectasia, angiomas and various other aesthetic conditions.
Cannabinoid products may alter effects of prescription drugs
August 5th 2020Researchers have identified and developed lists of medications that may not function properly due to concomitant cannabinoid use in an effort to help medical professionals prescribe prescription drugs safely to their patients.
FDA approves combination treatment for advanced melanoma
July 30th 2020The U.S. Food and Drug Administration has approved atezolizumab plus cobimetinib and vemurafenib for treatment of BRAF V600 mutation-positive advanced melanoma. Studies show the combination treatment prolonged patients’ lives by 15 months without disease worsening.
FDA approves plaque psoriasis topical
July 23rd 2020The U.S. Food and Drug Administration has approved Wynzora Cream (calcipotriene 0.005% and betamethasone dipropionate 0.064%, MC2 Therapeutics) for adult with plaque psoriasis. Wynzora is equipped with the MC2 Therapeutics’ patented PAD Technology and is currently under review in the EU.